tiprankstipranks
Advertisement
Advertisement

PCKROMA Stock Latest News

KROMATID Showcases Genomic Integrity Toolbox for CAR-NK Cell Therapies at ASGCT
Private CompaniesKROMATID Showcases Genomic Integrity Toolbox for CAR-NK Cell Therapies at ASGCT
2h ago
KROMA
KROMATID Highlights Genomic Integrity Tools for Cell and Gene Therapy
PremiumPrivate Companies
KROMATID Highlights Genomic Integrity Tools for Cell and Gene Therapy
8h ago
KROMA
KROMATID Positions Genomic Integrity Tools for Advancing Cell and Gene Therapies
PremiumPrivate Companies
KROMATID Positions Genomic Integrity Tools for Advancing Cell and Gene Therapies
1d ago
KROMA
KROMATID Highlights Visibility Challenges in In Vivo Gene Therapy
PremiumPrivate Companies
KROMATID Highlights Visibility Challenges in In Vivo Gene Therapy
6d ago
KROMA
KROMATID Emphasizes Genomic Visibility Challenges in In Vivo Therapeutic Engineering
PremiumPrivate Companies
KROMATID Emphasizes Genomic Visibility Challenges in In Vivo Therapeutic Engineering
6d ago
KROMA
Genomic Visibility Emphasized as Key Risk Factor in Cell and Gene Therapy
PremiumPrivate CompaniesGenomic Visibility Emphasized as Key Risk Factor in Cell and Gene Therapy
13d ago
KROMA
KROMATID Positions Genomic Risk Detection as Key Need in Cell and Gene Therapy
Premium
Private Companies
KROMATID Positions Genomic Risk Detection as Key Need in Cell and Gene Therapy
15d ago
KROMA
KROMATID Positions Genomic Integrity Analytics as Differentiator in Cell and Gene Therapy
Premium
Private Companies
KROMATID Positions Genomic Integrity Analytics as Differentiator in Cell and Gene Therapy
15d ago
KROMA
KROMATID Positions Genomic Analysis Capabilities in Expanding Cell and Gene Therapy Market
PremiumPrivate Companies
KROMATID Positions Genomic Analysis Capabilities in Expanding Cell and Gene Therapy Market
20d ago
KROMA
KROMATID Highlights Growing Demand for Genomic Tools in Expanding Cell and Gene Therapy Market
PremiumPrivate Companies
KROMATID Highlights Growing Demand for Genomic Tools in Expanding Cell and Gene Therapy Market
20d ago
KROMA
KROMATID Positions Genomic Integrity as Strategic Differentiator in Cell and Gene Therapy
PremiumPrivate Companies
KROMATID Positions Genomic Integrity as Strategic Differentiator in Cell and Gene Therapy
21d ago
KROMA
KROMATID Emphasizes Genomic Integrity Focus in Cell and Gene Therapy
PremiumPrivate Companies
KROMATID Emphasizes Genomic Integrity Focus in Cell and Gene Therapy
21d ago
KROMA
KROMATID Positions Genomic Insight Platform for In Vivo Gene Editing Safety
PremiumPrivate CompaniesKROMATID Positions Genomic Insight Platform for In Vivo Gene Editing Safety
22d ago
KROMA
Genomic Integrity Demand Rises With Commercial Progress in Cell and Gene Therapy
Premium
Private Companies
Genomic Integrity Demand Rises With Commercial Progress in Cell and Gene Therapy
28d ago
KROMA
Evolving Genomic Analysis Needs in Cell and Gene Therapy Highlight Market for Advanced Tools
Premium
Private Companies
Evolving Genomic Analysis Needs in Cell and Gene Therapy Highlight Market for Advanced Tools
28d ago
KROMA
Genomic Integrity Focus Signals Potential Demand for KROMATID Edit Risk Assessments
PremiumPrivate Companies
Genomic Integrity Focus Signals Potential Demand for KROMATID Edit Risk Assessments
29d ago
KROMA
Genomic Risk Assessment Demand Highlighted in Gene Editing Quality Control
PremiumPrivate Companies
Genomic Risk Assessment Demand Highlighted in Gene Editing Quality Control
29d ago
KROMA
KROMATID Highlights Genomic Integrity Expertise in CRISPR-Edited Stem Cell Therapies
PremiumPrivate Companies
KROMATID Highlights Genomic Integrity Expertise in CRISPR-Edited Stem Cell Therapies
1M ago
KROMA
Early Genomic Integrity Testing Emerges as Focus in Cell Therapy Development
PremiumPrivate Companies
Early Genomic Integrity Testing Emerges as Focus in Cell Therapy Development
1M ago
KROMA
Cell Therapy Development Risks Underscore Need for Genomic Integrity Monitoring
PremiumPrivate CompaniesCell Therapy Development Risks Underscore Need for Genomic Integrity Monitoring
1M ago
KROMA
KROMATID Highlights Need for Comprehensive Genomic QC in Gene Editing
Premium
Private Companies
KROMATID Highlights Need for Comprehensive Genomic QC in Gene Editing
1M ago
KROMA
KROMATID Highlights Genomic Analysis Applications for Cell and Gene Therapy
Premium
Private Companies
KROMATID Highlights Genomic Analysis Applications for Cell and Gene Therapy
1M ago
KROMA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >